AWP
LLY icon

Accretive Wealth Partners’s Eli Lilly LLY Stock Holding History

Accretive Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Hold
222
– – 0.06% 169
2025
Q4 		$239K Buy
+222
New +$212K 0.07% 142

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Accretive Wealth Partners's LLY Position: Q1 2026 in Review

Accretive Wealth Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 222 shares worth $204K. The position accounts for 0.06% of the portfolio, ranked #169.

Accretive Wealth Partners first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $239K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Accretive Wealth Partners held 222 shares of Eli Lilly worth $204K as of Q1 2026.
  • Accretive Wealth Partners left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.06% of Accretive Wealth Partners's portfolio in Q1 2026, its #169 holding.
  • Accretive Wealth Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Accretive Wealth Partners's Eli Lilly position peaked at $239K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.